|
HY-100500-10mg
|
MedChemexpress LLC
|
Lenampicillin (hydrochloride) [CAS 80734-02-7]
|
|
Cancer-programmed cell death
|
|
|
HY-100500-5mg
|
MedChemexpress LLC
|
Lenampicillin (hydrochloride) [CAS 80734-02-7]
|
|
Cancer-programmed cell death
|
|
|
HY-101559-50ug
|
MedChemexpress LLC
|
10-Nitrooleic acid [CAS 875685-46-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-101559S-100ug
|
MedChemexpress LLC
|
10-Nitrooleate-d17 (nitrate) [CAS 2749984-40-3]
|
|
|
|
|
HY-10225-10mg
|
MedChemexpress LLC
|
Belinostat [CAS 866323-14-0]
|
|
Cancer-programmed cell death
|
|
|
HY-10225-100mg
|
MedChemexpress LLC
|
Belinostat [CAS 866323-14-0]
|
|
Cancer-programmed cell death
|
|
|
HY-10225-200mg
|
MedChemexpress LLC
|
Belinostat [CAS 866323-14-0]
|
|
Cancer-programmed cell death
|
|
|
HY-10225-5mg
|
MedChemexpress LLC
|
Belinostat [CAS 866323-14-0]
|
|
Cancer-programmed cell death
|
|
|
HY-10225-50mg
|
MedChemexpress LLC
|
Belinostat [CAS 866323-14-0]
|
|
Cancer-programmed cell death
|
|
|
HY-10294-10mg
|
MedChemexpress LLC
|
Relacatib [CAS 362505-84-8]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-10294-25mg
|
MedChemexpress LLC
|
Relacatib [CAS 362505-84-8]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-10294-5mg
|
MedChemexpress LLC
|
Relacatib [CAS 362505-84-8]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-103243-10mg
|
MedChemexpress LLC
|
TCPOBOP [CAS 76150-91-9]
|
|
Cancer-programmed cell death
|
|
|
HY-103243-100mg
|
MedChemexpress LLC
|
TCPOBOP [CAS 76150-91-9]
|
|
Cancer-programmed cell death
|
|
|
HY-103243-25mg
|
MedChemexpress LLC
|
TCPOBOP [CAS 76150-91-9]
|
|
Cancer-programmed cell death
|
|
|
HY-103243-5mg
|
MedChemexpress LLC
|
TCPOBOP [CAS 76150-91-9]
|
|
Cancer-programmed cell death
|
|
|
HY-103243-50mg
|
MedChemexpress LLC
|
TCPOBOP [CAS 76150-91-9]
|
|
Cancer-programmed cell death
|
|
|
HY-10569-10mg
|
MedChemexpress LLC
|
Ponesimod [CAS 854107-55-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-10569-100mg
|
MedChemexpress LLC
|
Ponesimod [CAS 854107-55-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-10569-5mg
|
MedChemexpress LLC
|
Ponesimod [CAS 854107-55-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-10569-50mg
|
MedChemexpress LLC
|
Ponesimod [CAS 854107-55-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-105808-10mg
|
MedChemexpress LLC
|
Furobufen [CAS 38873-55-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-105808-100mg
|
MedChemexpress LLC
|
Furobufen [CAS 38873-55-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-105808-5mg
|
MedChemexpress LLC
|
Furobufen [CAS 38873-55-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-105808-50mg
|
MedChemexpress LLC
|
Furobufen [CAS 38873-55-1]
|
|
COVID-19-immunoregulation
|
|
